APO RESEARCH · REPORT
Life Sciences Next-generation Customer Engagement Platforms (CEP)
Selected research
Market Outlook & Growth Opportunities
Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Market Outlook and Growth Opportunities 2026
Market perspective
The global Life Sciences Next-generation Customer Engagement Platforms (CEP) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Life Sciences Next-generation Customer Engagement Platforms (CEP) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Life Sciences Next-generation Customer Engagement Platforms (CEP) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Life Sciences Next-generation Customer Engagement Platforms (CEP) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Life Sciences Next-generation Customer Engagement Platforms (CEP) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Life Sciences Next-generation Customer Engagement Platforms (CEP) market include Veeva, IQVIA, Pitcher, Exeevo, Trueblue, WhizAI, Aktana, Salesforce and Tact.ai, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Life Sciences Next-generation Customer Engagement Platforms (CEP) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Life Sciences Next-generation Customer Engagement Platforms (CEP) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Life Sciences Next-generation Customer Engagement Platforms (CEP) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Life Sciences Next-generation Customer Engagement Platforms (CEP) market.
Life Sciences Next-generation Customer Engagement Platforms (CEP) Segment by Company
Veeva
IQVIA
Pitcher
Exeevo
Trueblue
WhizAI
Aktana
Salesforce
Tact.ai
ACTO
Viseven
Bigtincan
ODAIA
Allego
Seismic
Tellius
Vodori
ZS Associates
Qstream
Life Sciences Next-generation Customer Engagement Platforms (CEP) Segment by Type
Cloud Based
On-premises
Life Sciences Next-generation Customer Engagement Platforms (CEP) Segment by Application
Pharmaceutical
Biotechnology Companies
Medical Device Companies
Others
Life Sciences Next-generation Customer Engagement Platforms (CEP) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Life Sciences Next-generation Customer Engagement Platforms (CEP) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Life Sciences Next-generation Customer Engagement Platforms (CEP) key companies, revenue, market share, and recent developments.
3. To split the Life Sciences Next-generation Customer Engagement Platforms (CEP) breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Life Sciences Next-generation Customer Engagement Platforms (CEP) market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Life Sciences Next-generation Customer Engagement Platforms (CEP) significant trends, drivers, influence factors in global and regions.
6. To analyze Life Sciences Next-generation Customer Engagement Platforms (CEP) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Life Sciences Next-generation Customer Engagement Platforms (CEP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Life Sciences Next-generation Customer Engagement Platforms (CEP) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Life Sciences Next-generation Customer Engagement Platforms (CEP).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Life Sciences Next-generation Customer Engagement Platforms (CEP) industry.
Chapter 3: Detailed analysis of Life Sciences Next-generation Customer Engagement Platforms (CEP) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Life Sciences Next-generation Customer Engagement Platforms (CEP) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Life Sciences Next-generation Customer Engagement Platforms (CEP) in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud Based
- On-premises
Applications
- Pharmaceutical
- Biotechnology Companies
- Medical Device Companies
- Others
Companies covered
- Veeva
- IQVIA
- Pitcher
- Exeevo
- Trueblue
- WhizAI
- Aktana
- Salesforce
- Tact.ai
- ACTO
- Viseven
- Bigtincan
- ODAIA
- Allego
- Seismic
- Tellius
- Vodori
- ZS Associates
- Qstream
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Life Sciences Next-generation Customer Engagement Platforms (CEP) Market Dynamics
- 2.1 Life Sciences Next-generation Customer Engagement Platforms (CEP) Industry Trends
- 2.2 Life Sciences Next-generation Customer Engagement Platforms (CEP) Industry Drivers
- 2.3 Life Sciences Next-generation Customer Engagement Platforms (CEP) Industry Opportunities and Challenges
- 2.4 Life Sciences Next-generation Customer Engagement Platforms (CEP) Industry Restraints
3 Life Sciences Next-generation Customer Engagement Platforms (CEP) Market by Company
- 3.1 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Company Revenue Ranking in 2025
- 3.2 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue by Company (2021-2026)
- 3.3 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Company Ranking (2024-2026)
- 3.4 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Company Manufacturing Base and Headquarters
- 3.5 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Company Product Type and Application
- 3.6 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Life Sciences Next-generation Customer Engagement Platforms (CEP) Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Life Sciences Next-generation Customer Engagement Platforms (CEP) Market by Type
- 4.1 Life Sciences Next-generation Customer Engagement Platforms (CEP) Type Introduction
- 4.1.1 Cloud Based
- 4.1.2 On-premises
- 4.2 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value by Type
- 4.2.1 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value by Type (2021-2032)
- 4.2.3 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type (2021-2032)
5 Life Sciences Next-generation Customer Engagement Platforms (CEP) Market by Application
- 5.1 Life Sciences Next-generation Customer Engagement Platforms (CEP) Application Introduction
- 5.1.1 Pharmaceutical
- 5.1.2 Biotechnology Companies
- 5.1.3 Medical Device Companies
- 5.1.4 Others
- 5.2 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value by Application
- 5.2.1 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value by Application (2021-2032)
- 5.2.3 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application (2021-2032)
6 Life Sciences Next-generation Customer Engagement Platforms (CEP) Regional Value Analysis
- 6.1 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value by Region (2021-2032)
- 6.2.1 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value by Region: 2021-2026
- 6.2.2 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value (2021-2032)
- 6.3.2 North America Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value (2021-2032)
- 6.4.2 Europe Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value (2021-2032)
- 6.6.2 South America Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Country, 2025 VS 2032
7 Life Sciences Next-generation Customer Engagement Platforms (CEP) Country-level Value Analysis
- 7.1 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value by Country (2021-2032)
- 7.2.1 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value by Country (2021-2026)
- 7.2.2 Global Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.7.2 France Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.14.2 China Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.17.2 India Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Life Sciences Next-generation Customer Engagement Platforms (CEP) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Veeva
- 8.1.1 Veeva Company Information
- 8.1.2 Veeva Business Overview
- 8.1.3 Veeva Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.1.4 Veeva Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.1.5 Veeva Recent Developments
- 8.2 IQVIA
- 8.2.1 IQVIA Company Information
- 8.2.2 IQVIA Business Overview
- 8.2.3 IQVIA Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.2.4 IQVIA Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.2.5 IQVIA Recent Developments
- 8.3 Pitcher
- 8.3.1 Pitcher Company Information
- 8.3.2 Pitcher Business Overview
- 8.3.3 Pitcher Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.3.4 Pitcher Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.3.5 Pitcher Recent Developments
- 8.4 Exeevo
- 8.4.1 Exeevo Company Information
- 8.4.2 Exeevo Business Overview
- 8.4.3 Exeevo Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.4.4 Exeevo Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.4.5 Exeevo Recent Developments
- 8.5 Trueblue
- 8.5.1 Trueblue Company Information
- 8.5.2 Trueblue Business Overview
- 8.5.3 Trueblue Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.5.4 Trueblue Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.5.5 Trueblue Recent Developments
- 8.6 WhizAI
- 8.6.1 WhizAI Company Information
- 8.6.2 WhizAI Business Overview
- 8.6.3 WhizAI Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.6.4 WhizAI Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.6.5 WhizAI Recent Developments
- 8.7 Aktana
- 8.7.1 Aktana Company Information
- 8.7.2 Aktana Business Overview
- 8.7.3 Aktana Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.7.4 Aktana Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.7.5 Aktana Recent Developments
- 8.8 Salesforce
- 8.8.1 Salesforce Company Information
- 8.8.2 Salesforce Business Overview
- 8.8.3 Salesforce Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.8.4 Salesforce Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.8.5 Salesforce Recent Developments
- 8.9 Tact.ai
- 8.9.1 Tact.ai Company Information
- 8.9.2 Tact.ai Business Overview
- 8.9.3 Tact.ai Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.9.4 Tact.ai Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.9.5 Tact.ai Recent Developments
- 8.10 ACTO
- 8.10.1 ACTO Company Information
- 8.10.2 ACTO Business Overview
- 8.10.3 ACTO Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.10.4 ACTO Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.10.5 ACTO Recent Developments
- 8.11 Viseven
- 8.11.1 Viseven Company Information
- 8.11.2 Viseven Business Overview
- 8.11.3 Viseven Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.11.4 Viseven Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.11.5 Viseven Recent Developments
- 8.12 Bigtincan
- 8.12.1 Bigtincan Company Information
- 8.12.2 Bigtincan Business Overview
- 8.12.3 Bigtincan Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.12.4 Bigtincan Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.12.5 Bigtincan Recent Developments
- 8.13 ODAIA
- 8.13.1 ODAIA Company Information
- 8.13.2 ODAIA Business Overview
- 8.13.3 ODAIA Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.13.4 ODAIA Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.13.5 ODAIA Recent Developments
- 8.14 Allego
- 8.14.1 Allego Company Information
- 8.14.2 Allego Business Overview
- 8.14.3 Allego Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.14.4 Allego Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.14.5 Allego Recent Developments
- 8.15 Seismic
- 8.15.1 Seismic Company Information
- 8.15.2 Seismic Business Overview
- 8.15.3 Seismic Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.15.4 Seismic Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.15.5 Seismic Recent Developments
- 8.16 Tellius
- 8.16.1 Tellius Company Information
- 8.16.2 Tellius Business Overview
- 8.16.3 Tellius Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.16.4 Tellius Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.16.5 Tellius Recent Developments
- 8.17 Vodori
- 8.17.1 Vodori Company Information
- 8.17.2 Vodori Business Overview
- 8.17.3 Vodori Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.17.4 Vodori Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.17.5 Vodori Recent Developments
- 8.18 ZS Associates
- 8.18.1 ZS Associates Company Information
- 8.18.2 ZS Associates Business Overview
- 8.18.3 ZS Associates Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.18.4 ZS Associates Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.18.5 ZS Associates Recent Developments
- 8.19 Qstream
- 8.19.1 Qstream Company Information
- 8.19.2 Qstream Business Overview
- 8.19.3 Qstream Life Sciences Next-generation Customer Engagement Platforms (CEP) Revenue and Gross Margin (2021-2026)
- 8.19.4 Qstream Life Sciences Next-generation Customer Engagement Platforms (CEP) Product Portfolio
- 8.19.5 Qstream Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst